OMITTED

What the news leaves out.

Debates · GLP-1 drugs and metabolism

Do GLP-1 weight-loss medications inherently lead to clinically significant long-term loss of muscle mass and strength for most users?

6 shows · 8 speakers · published Nov 12, 2026 · updated Nov 13, 2026

The debate

Podcasts debate whether GLP-1 weight-loss drugs inherently cause clinically significant, long-term loss of muscle mass and strength for most users. Bhattacharya (Culture Apothecary) and Bikman (The Diary Of A CEO) argue in January episodes that GLP-1 use can cause large, possibly permanent losses of lean mass. Haver (unPAUSED) and Lyon (unPAUSED) argue from late March through late September episodes that GLP-1 drugs can be used without major muscle loss when combined with protein and resistance training.

Where each side stands

Yes, GLP-1 drugs typically cause substantial, lasting muscle and strength loss in most users.

Dr. Jay Bhattacharya (Culture Apothecary) · Benjamin Bikman (The Diary Of A CEO) · Chris Thompson (Huberman Lab) · Will Ahmed (All-In) · David Jockers (Dr. Jockers Functional Nutrition)

Ahmed (All-In) says about half of the weight lost on GLP-1 drugs is muscle rather than fat, which he links to people becoming frail after weight loss. Thompson (Huberman Lab) states that roughly one third of the weight lost on GLP-1 therapy is lean mass, and cycling on and off leads to progressively worse body composition. Thompson reports that patients stop GLP-1 drugs because they notice muscle loss, including visible changes like 'Ozempic face' or development of sarcopenia. Bikman warns that after stopping GLP-1 drugs, fat mass tends to return while lost muscle and bone mass may never come back.

6 claims, in their words
  • “We don't know, it's like if you're on Ozempic for a while, you lose weight and you get off of it, you know, you start to gain your weight back. Is, is it, is, is there some transition that like makes it your, that, that actually poses a health threat to you? there's like some evidence of muscle loss.”
    Dr. Jay Bhattacharya · Culture Apothecary · 2026-01-03 · 35:10 nothing cited
  • “If she's lost weight now and then two years later wants to get off the drug, like 70% of people do, she will, her fat mass will come right back, but her lean mass may never come back. That muscle and bone may be gone for good.”
    Benjamin Bikman · The Diary Of A CEO · 2026-01-08 · 1:35:02 nothing cited
  • “when you lose weight, about a third of the weight you lose would be lean mass, right? So most muscle, right? Maybe some bone, et cetera. And the problem is when you cycle on and off, right? So say you come off of it and you put your weight back on, you're not putting the lean mass back on, okay?”
    Chris Thompson · Huberman Lab · 2026-09-21 · 36:02 cites a number
  • “I think that muscle loss, honestly, is one of the bigger ones, right? And it might just be subtle, like ozempic face, ozempic butt, right? You're losing some muscle in places where it's noticeable. Other people actually truly develop sarcopenia, I think, right? Where you have significant loss of muscle.”
    Chris Thompson · Huberman Lab · 2026-09-21 · 38:42 personal experienceThe primary reasons that I hear
  • “typically speaking about 50% of the weight that someone loses is fat and 50% is muscle. And, you know, so that's how sometimes people can end up getting quite frail, even though they've lost a considerable amount of weight.”
    Will Ahmed · All-In · 2026-10-29 · 33:08 cites a number
  • “with those medications, you're actually losing muscle mass.”
    David Jockers · Dr. Jockers Functional Nutrition · 2026-11-03 · 36:43 nothing cited

No, when appropriately managed they do not inherently cause substantial long-term muscle or strength loss.

Mary Claire Haver (unPAUSED with Dr. Mary Claire Haver) · Gabrielle Lyon (unPAUSED with Dr. Mary Claire Haver) · Pamela Brown (unPAUSED with Dr. Mary Claire Haver)

Haver (unPAUSED) says GLP-1 use should be paired with high protein intake and strength training, describing this combined approach as the 'GPS protocol'. Lyon (unPAUSED) reports her clinic uses lower GLP-1 doses plus managed nutrition and resistance training to give the drugs without causing muscle loss. Lyon states that GLP-1 drugs do not uniquely destroy muscle but that muscle loss simply tracks with the percentage of body weight lost. Lyon adds that emerging data suggest GLP-1 treatment can improve muscle quality by lowering fat stored within muscle tissue.

8 claims, in their words
  • “I was skeptical until. I started following Dr. Jenna Siwak and Dr. Rocio Salas-Whalen on social and looking at the medical research journal articles they were presenting and then pulling them myself and reading them myself and realizing, wait a minute, I am allowing my own bias to stand in the way of what is, what could be potentially best”
    Mary Claire Haver · unPAUSED with Dr. Mary Claire Haver · 2026-03-31 · 51:41 personal experience
  • “I started following Dr. Jenna Siwak and Dr. Rocio Salas-Whalen on social and looking at the medical research journal articles they were presenting and then pulling them myself and reading them myself and realizing, wait a minute, I am allowing my own bias to stand in the way of what is, what could be potentially best for a patient”
    Mary Claire Haver · unPAUSED with Dr. Mary Claire Haver · 2026-03-31 · 53:39 personal experience
  • “The GLP-1 is simply a tool in the toolkit. There are multiple tools in the toolkit, adequate resistance training, adequate cardio, you know, exercising your body, lowering your stress, focusing on your sleep, doing all the things that are going to make a healthier body and help these medications help you.”
    Mary Claire Haver · unPAUSED with Dr. Mary Claire Haver · 2026-03-31 · 56:26 nothing cited
  • “We do in our clinic, and we manage nutrition and resistance training and lower dosing. Of these medications, it doesn't have to be very high doses.”
    Gabrielle Lyon · unPAUSED with Dr. Mary Claire Haver · 2026-09-25 · 40:29 personal experience
  • “They track in line with when an individual Loses weight, we see it's the same percentage. It's not something magical, but the problem is if individuals are abusing GLP-1s, not training, seeing the celebrity sphere become very skinny, sarcopenic, I believe that we're going to have an epidemic of sarcopenia that we defined as an aging change in muscle accelerated”
    Gabrielle Lyon · unPAUSED with Dr. Mary Claire Haver · 2026-09-25 · 41:25 nothing cited
  • “The data, I believe, that is coming out and will continue to come out improves muscle quality, lowering the fat within the muscle.”
    Gabrielle Lyon · unPAUSED with Dr. Mary Claire Haver · 2026-09-25 · 40:43 nothing cited
  • “everyone wants to know about like the sunken face or the flat butt. How do you prevent that on GLP-1? So we talked a little bit about that. ... you got to really make sure you're eating the protein. ... And you're, you're doing the strength training. Non-negotiable.”
    Pamela Brown · unPAUSED with Dr. Mary Claire Haver · 2026-10-09 · 16:04 nothing cited
  • “the GPS protocol, which is GLP-1 protein strength training. They have to go together.”
    Mary Claire Haver · unPAUSED with Dr. Mary Claire Haver · 2026-10-09 · 16:24 cites an event
What each side never hears

Listeners of “Yes, GLP-1 drugs typically cause substantial, lasting muscle and strength loss in most users.” have not heard (5 arguments)

Listeners of these shows have not heard Haver's shift from skepticism to supporting GLP-1 use after personally reviewing research presented by Siwak and Salas-Whalen. Haver also describes GLP-1s as one tool among others like resistance training and cardio within a broader plan for health. Brown explains that focusing on adequate protein intake and strength training is her answer to questions about avoiding a sunken face or flat butt on GLP-1 drugs. Haver emphasizes that GLP-1 therapy, protein intake, and strength training must go together in what she calls the GPS protocol.

5 unanswered arguments, in their words
  • “The GLP-1 is simply a tool in the toolkit. There are multiple tools in the toolkit, adequate resistance training, adequate cardio, you know, exercising your body, lowering your stress, focusing on your sleep, doing all the things that are going to make a healthier body and help these medications help you.”
    Mary Claire Haver · unPAUSED with Dr. Mary Claire Haver · 2026-03-31 · unanswered for 32 weeks
  • “the GPS protocol, which is GLP-1 protein strength training. They have to go together.”
    Mary Claire Haver · unPAUSED with Dr. Mary Claire Haver · 2026-10-09 · GPS protocolunanswered for 5 weeks
  • “everyone wants to know about like the sunken face or the flat butt. How do you prevent that on GLP-1? So we talked a little bit about that. ... you got to really make sure you're eating the protein. ... And you're, you're doing the strength training. Non-negotiable.”
    Pamela Brown · unPAUSED with Dr. Mary Claire Haver · 2026-10-09 · unanswered for 5 weeks
  • “I was skeptical until. I started following Dr. Jenna Siwak and Dr. Rocio Salas-Whalen on social and looking at the medical research journal articles they were presenting and then pulling them myself and reading them myself and realizing, wait a minute, I am allowing my own bias to stand in the way of what is, what could be potentially best”
    Mary Claire Haver · unPAUSED with Dr. Mary Claire Haver · 2026-03-31 · following Dr. Jenna Siwak and Dr. Rocio Salas-Whalen research articlesunanswered for 32 weeks
  • “We do in our clinic, and we manage nutrition and resistance training and lower dosing. Of these medications, it doesn't have to be very high doses.”
    Gabrielle Lyon · unPAUSED with Dr. Mary Claire Haver · 2026-09-25 · our clinicunanswered for 7 weeks

Listeners of “No, when appropriately managed they do not inherently cause substantial long-term muscle or strength loss.” have not heard (1 argument)

Bikman argues that after stopping GLP-1 drugs, fat mass usually returns while lost muscle and bone mass may be gone permanently.

1 unanswered argument, in their words
  • “If she's lost weight now and then two years later wants to get off the drug, like 70% of people do, she will, her fat mass will come right back, but her lean mass may never come back. That muscle and bone may be gone for good.”
    Benjamin Bikman · The Diary Of A CEO · 2026-01-08 · unanswered for 44 weeks
Bottom line

Supporters of position 0 lean on reports of large, possibly permanent lean-mass losses, which position 1's shows do not directly address. Supporters of position 1 focus on protocols combining GLP-1s with protein and resistance training, which position 0's shows never discuss in comparable detail.

2 arguments the other side has addressed
Argument
“They track in line with when an individual Loses weight, we see it's the same percentage. It's not something magical, but the problem is if individuals are abusing GLP-1s, not training, seeing the celebrity sphere become very skinny, sarcopenic, I believe that we're going to have an epidemic of sarcopenia that we defined as an aging change in muscle accelerated”
Gabrielle Lyon · unPAUSED with Dr. Mary Claire Haver · 2026-09-25 · 41:25
Addressed by
“when you lose weight, about a third of the weight you lose would be lean mass, right? So most muscle, right? Maybe some bone, et cetera. And the problem is when you cycle on and off, right? So say you come off of it and you put your weight back on, you're not putting the lean mass back on, okay?”
Chris Thompson · Huberman Lab · 2026-09-21 · 36:02 · different episodes
Argument
“when you lose weight, about a third of the weight you lose would be lean mass, right? So most muscle, right? Maybe some bone, et cetera. And the problem is when you cycle on and off, right? So say you come off of it and you put your weight back on, you're not putting the lean mass back on, okay?”
Chris Thompson · Huberman Lab · 2026-09-21 · 36:02
Addressed by
“They track in line with when an individual Loses weight, we see it's the same percentage. It's not something magical, but the problem is if individuals are abusing GLP-1s, not training, seeing the celebrity sphere become very skinny, sarcopenic, I believe that we're going to have an epidemic of sarcopenia that we defined as an aging change in muscle accelerated”
Gabrielle Lyon · unPAUSED with Dr. Mary Claire Haver · 2026-09-25 · 41:25 · different episodes
What changed

Published because: 6 shows, 2 positions, 304 days of debate. Questions publish only when claims come from at least three shows, at least two positions are held by different people, and the debate has lasted two weeks.

Pairs are matched by content across different episodes and shows; no exchange between these speakers took place unless both quotes come from the same episode.

The prose on this page is written by a model from the quotes shown, and every sentence of it rests on quotes you can open; sentences that could not be traced to a quote were removed before publishing. Positions are placed from each speaker's own words. Evidence labels say what the speaker cited, never whether it is true.

8 episodes behind this page

The week's bottom lines, in your inbox

One email a week: the stories that mattered and what they actually mean. Free.